BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22067014)

  • 1. An evaluation of a novel instrument for measuring macular pigment optical density: the MPS 9000.
    Loughman J; Scanlon G; Nolan JM; O'Dwyer V; Beatty S
    Acta Ophthalmol; 2012 Mar; 90(2):e90-7. PubMed ID: 22067014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated measures of macular pigment optical density to test reproducibility of heterochromatic flicker photometry.
    Hagen S; Krebs I; Glittenberg C; Binder S
    Acta Ophthalmol; 2010 Mar; 88(2):207-11. PubMed ID: 19094168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of macular pigment: Raman spectroscopy versus heterochromatic flicker photometry.
    Neelam K; O'Gorman N; Nolan J; O'Donovan O; Wong HB; Au Eong KG; Beatty S
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1023-32. PubMed ID: 15728561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of the MacuScope macular pigment densitometer.
    Bartlett H; Acton J; Eperjesi F
    Br J Ophthalmol; 2010 Mar; 94(3):328-31. PubMed ID: 19850583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of macular pigment optical density using two different heterochromatic flicker photometers.
    Loane E; Stack J; Beatty S; Nolan JM
    Curr Eye Res; 2007 Jun; 32(6):555-64. PubMed ID: 17612971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of the MPS 9000 Macular Pigment Screener.
    Bartlett H; Stainer L; Singh S; Eperjesi F; Howells O
    Br J Ophthalmol; 2010 Jun; 94(6):753-6. PubMed ID: 20508051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between macular pigment optical density measurements using two-wavelength autofluorescence and heterochromatic flicker photometry techniques.
    Canovas R; Lima VC; Garcia P; Morini C; Prata TS; Rosen RB
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3152-6. PubMed ID: 19578017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance.
    Kaya S; Weigert G; Pemp B; Sacu S; Werkmeister RM; Dragostinoff N; Garhöfer G; Schmidt-Erfurth U; Schmetterer L
    Acta Ophthalmol; 2012 Aug; 90(5):e399-403. PubMed ID: 23035764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype is associated with macular pigment optical density.
    Loane E; McKay GJ; Nolan JM; Beatty S
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2636-43. PubMed ID: 20107178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of macular pigment assessment in clinical practice: a review.
    Bartlett H; Howells O; Eperjesi F
    Clin Exp Optom; 2010 Sep; 93(5):300-8. PubMed ID: 20629669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular Pigment Reflectometry: Developing Clinical Protocols, Comparison with Heterochromatic Flicker Photometry and Individual Carotenoid Levels.
    Davey PG; Rosen RB; Gierhart DL
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
    Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J
    Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
    Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J
    Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance.
    Dennison JL; Stack J; Beatty S; Nolan JM
    Exp Eye Res; 2013 Nov; 116():190-8. PubMed ID: 24007642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the repeatability of heterochromatic flicker photometry for measurement of macular pigment optical density.
    Howells O; Eperjesi F; Bartlett H
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):871-80. PubMed ID: 22899455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation on the noninvasive measurement of macular pigment optical density by a novel technique].
    Han X; Ren X; Li X; Zhang J; Yu J; Liu N
    Zhonghua Yan Ke Za Zhi; 2015 Nov; 51(11):826-30. PubMed ID: 26850584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2.
    Charbel Issa P; van der Veen RL; Stijfs A; Holz FG; Scholl HP; Berendschot TT
    Exp Eye Res; 2009 Jun; 89(1):25-31. PubMed ID: 19233170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial profile of macular pigment and its relationship to foveal architecture.
    Nolan JM; Stringham JM; Beatty S; Snodderly DM
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
    Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.